<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00814450</url>
  </required_header>
  <id_info>
    <org_study_id>ASNG-LFNA-101-IL</org_study_id>
    <nct_id>NCT00814450</nct_id>
  </id_info>
  <brief_title>Safety &amp; Accuracy of the ActiSight Needle Guidance System in Percutaneous Chest Aspiration and Biopsy</brief_title>
  <acronym>ANGS-PCAB</acronym>
  <official_title>A Prospective, Open-Label, Single-Arm, Single-Center Study Evaluating The Preliminary Safety And Accuracy Of The Actisight™ Needle Guidance System In Patients Undergoing CT-Guided Percutaneous Chest Aspiration And Biopsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ActiViews Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ActiViews Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is intended to provide clinical data regarding safety and accuracy of the
      ActiSight™ Needle Guidance System in assisting Chest CT guided biopsies.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of target reached within a radius of 8 mm from the preplanned targeted point as measured on the final CT scan.</measure>
    <time_frame>Measure evaluated during entire course of study</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of needle punctures through the skin</measure>
    <time_frame>Measure evaluated during entire course of study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of needle punctures through the pleura</measure>
    <time_frame>Measure evaluated during entire course of study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of CT scans needed</measure>
    <time_frame>Measure evaluated during entire course of study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radial distance at target plane at the needle's final position as shown on the ActiSight screen</measure>
    <time_frame>Measure evaluated during entire course of study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events following the procedure, including the following:Pneumothorax, Hemoptysis &gt;100 ml, Bleeding, Collapsed lung, Chest drainage, Need for hospitalization</measure>
    <time_frame>Measure evaluated during entire course of study</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">20</enrollment>
  <condition>Biopsy</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biopsy needle guidance system (ActiSight™)</intervention_name>
    <description>The ActiSight system assists in guiding an aspiration or biopsy needle, to a designated point within the body by means of CT visualization.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female subjects, 18 years of age or older at the time of enrollment

          -  Subjects meeting all medical conditions for percutaneous chest aspiration/biopsy with
             safe path to lesion between ribs, however, not in the breast area in women or men with
             gynecomastia

          -  Single target pulmonary lesion greater than 10 mm in size (diameter) and depth of
             lesion greater than 40 mm from the skin

          -  INR &lt;1.3

          -  Written informed consent to participate in the study

          -  Ability to comply with the requirements of the study procedures

        Exclusion Criteria:

          -  Fibrous tissue or cyst in access path (not including target lesion)

          -  Hemophilia, thrombocytopenia, coagulopathy, or other elevated risk for bleeding or
             abnormal clotting

          -  Central lesion is located in radius of less than 2 cm from lobar blood vessels and the
             heart.

          -  The selected needle path has a safety margin of less than 2 cm from major blood
             vessels and the heart

          -  Use of ticlopidine or similar antithrombotic medication

          -  For subjects taking warfarin or other anticoagulant medication, INR &gt;1.3

          -  Pulmonary hypertension, heart failure, renal failure, or blood dyscrasia

          -  Subjects who cannot tolerate mild sedation

          -  Subjects with FEV1 &lt; 800 mL unless approved by principal investigator following
             consultation with multidisciplinary team

          -  Subjects with the following laboratory values, unless approved by hematologist:

               -  Platelet count &lt;100,000/mL

               -  APTT &gt;39 sec or PT &gt;15 sec

          -  Pregnancy or lactation

          -  Patient is unable to comply with requirements of the procedure, i.e. holding breath

          -  Participation in an investigational trial within 30 days of enrollment

          -  Any form of substance abuse (including drug or alcohol abuse), psychiatric disorder,
             or any chronic condition that could, in the opinion of the investigator, of
             interfering with the conduct of the study.

          -  Subjects who are uncooperative or cannot follow instructions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Boaz Tiran, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel-Aviv Sourasky Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 23, 2008</study_first_submitted>
  <study_first_submitted_qc>December 23, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2008</study_first_posted>
  <last_update_submitted>December 29, 2009</last_update_submitted>
  <last_update_submitted_qc>December 29, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 30, 2009</last_update_posted>
  <responsible_party>
    <name_title>Uri Shreter/ Medical Director</name_title>
    <organization>Activiews</organization>
  </responsible_party>
  <keyword>Biopsy</keyword>
  <keyword>Fine needle aspiration</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

